These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 22796097)

  • 41. Can currently available non-animal methods detect pre and pro-haptens relevant for skin sensitization?
    Patlewicz G; Casati S; Basketter DA; Asturiol D; Roberts DW; Lepoittevin JP; Worth AP; Aschberger K
    Regul Toxicol Pharmacol; 2016 Dec; 82():147-155. PubMed ID: 27569201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Skin sensitization testing in potency and risk assessment.
    Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
    Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predicting skin sensitizer potency based on in vitro data from KeratinoSens and kinetic peptide binding: global versus domain-based assessment.
    Natsch A; Emter R; Gfeller H; Haupt T; Ellis G
    Toxicol Sci; 2015 Feb; 143(2):319-32. PubMed ID: 25338925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of skin sensitization potency using machine learning approaches.
    Zang Q; Paris M; Lehmann DM; Bell S; Kleinstreuer N; Allen D; Matheson J; Jacobs A; Casey W; Strickland J
    J Appl Toxicol; 2017 Jul; 37(7):792-805. PubMed ID: 28074598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison and validation of an in vitro skin sensitization strategy using a data set of 33 chemical references.
    Clouet E; Kerdine-Römer S; Ferret PJ
    Toxicol In Vitro; 2017 Dec; 45(Pt 3):374-385. PubMed ID: 28539215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrated decision strategies for skin sensitization hazard.
    Strickland J; Zang Q; Kleinstreuer N; Paris M; Lehmann DM; Choksi N; Matheson J; Jacobs A; Lowit A; Allen D; Casey W
    J Appl Toxicol; 2016 Sep; 36(9):1150-62. PubMed ID: 26851134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Applicability of an Integrated Testing Strategy consisting of in silico, in chemico and in vitro assays for evaluating the skin sensitization potencies of isocyanates.
    Ohtake T; Maeda Y; Hayashi T; Yamanaka H; Nakai M; Takeyoshi M
    Toxicology; 2018 Jan; 393():9-14. PubMed ID: 29100879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-animal assessment of skin sensitization hazard: Is an integrated testing strategy needed, and if so what should be integrated?
    Roberts DW; Patlewicz G
    J Appl Toxicol; 2018 Jan; 38(1):41-50. PubMed ID: 28543848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reconstructed human epidermis-based testing strategy of skin sensitization potential and potency classification using epidermal sensitization assay and in silico data.
    Mizumachi H; Suzuki S; Sakuma M; Natsui M; Imai N; Miyazawa M
    J Appl Toxicol; 2024 Mar; 44(3):415-427. PubMed ID: 37846211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of irritancy and sensitization potential of metalworking fluid mixtures and components.
    Anderson SE; Brown KK; Butterworth LF; Fedorowicz A; Jackson LG; Frasch HF; Beezhold D; Munson AE; Meade BJ
    J Immunotoxicol; 2009 Mar; 6(1):19-29. PubMed ID: 19519159
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
    Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
    Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a peptide reactivity assay for screening contact allergens.
    Gerberick GF; Vassallo JD; Bailey RE; Chaney JG; Morrall SW; Lepoittevin JP
    Toxicol Sci; 2004 Oct; 81(2):332-43. PubMed ID: 15254333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of an artificial neural network model for risk assessment of skin sensitization using human cell line activation test, direct peptide reactivity assay, KeratinoSens™ and in silico structure alert parameter.
    Hirota M; Ashikaga T; Kouzuki H
    J Appl Toxicol; 2018 Apr; 38(4):514-526. PubMed ID: 29226339
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of an ex vivo local lymph node assay to assess contact hypersensitivity potential.
    Piccotti JR; Kawabata TT
    J Immunotoxicol; 2008 Jul; 5(3):271-7. PubMed ID: 18830887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation.
    Natsch A; Ryan CA; Foertsch L; Emter R; Jaworska J; Gerberick F; Kern P
    J Appl Toxicol; 2013 Nov; 33(11):1337-52. PubMed ID: 23576290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of dermal sensitization potential for industrial or agricultural chemicals with EpiSensA.
    Mizumachi H; LeBaron MJ; Settivari RS; Miyazawa M; Marty MS; Sakaguchi H
    J Appl Toxicol; 2021 Jun; 41(6):915-927. PubMed ID: 33124094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative analysis of skin sensitization potency of acrylates (methyl acrylate, ethyl acrylate, butyl acrylate, and ethylhexyl acrylate) using the local lymph node assay.
    Dearman RJ; Betts CJ; Farr C; McLaughlin J; Berdasco N; Wiench K; Kimber I
    Contact Dermatitis; 2007 Oct; 57(4):242-7. PubMed ID: 17868217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Skin sensitization, false positives and false negatives: experience with guinea pig assays.
    Basketter DA; Kimber I
    J Appl Toxicol; 2010 Jul; 30(5):381-6. PubMed ID: 20583317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimation of relative skin sensitizing potency using the local lymph node assay: a comparison of formaldehyde with glutaraldehyde.
    Hilton J; Dearman RJ; Harvey P; Evans P; Basketter DA; Kimber I
    Am J Contact Dermat; 1998 Mar; 9(1):29-33. PubMed ID: 9471984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Myeloid U937 Skin Sensitization Test (U-SENS) addresses the activation of dendritic cell event in the adverse outcome pathway for skin sensitization.
    Piroird C; Ovigne JM; Rousset F; Martinozzi-Teissier S; Gomes C; Cotovio J; Alépée N
    Toxicol In Vitro; 2015 Aug; 29(5):901-16. PubMed ID: 25820135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.